{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:47:29Z","timestamp":1774615649890,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Genet"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12687-021-00518-3","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:02:54Z","timestamp":1619740974000},"page":"431-438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Baseline knowledge and receptiveness to genetic testing for hereditary breast and ovarian cancer syndromes in Chinese high-risk females"],"prefix":"10.1007","volume":"12","author":[{"given":"Annie Tsz-Wai","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiree Man-Sik","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dacita To Ki","family":"Suen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6968-9489","authenticated-orcid":false,"given":"Ava","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"518_CR1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg \u00c5, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrj\u00e4koski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130. https:\/\/doi.org\/10.1086\/375033","journal-title":"Am J Hum Genet"},{"key":"518_CR2","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jamaoncol.2015.3048","volume":"1","author":"J Armstrong","year":"2015","unstructured":"Armstrong J et al (2015) Utilization and outcomes of BRCA genetic testing and counseling in a national commercially insured population: the ABOUT study. JAMA Oncol 1:1251\u20131260. https:\/\/doi.org\/10.1001\/jamaoncol.2015.3048","journal-title":"JAMA Oncol"},{"key":"518_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"518_CR4","unstructured":"Census and Statistics Department (2018) Hong Kong in figures. Hong Kong"},{"issue":"3","key":"518_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1897-4287-4-3-126","volume":"4","author":"WS Chieng","year":"2006","unstructured":"Chieng WS, Lee SC (2006) Establishing a cancer genetics programme in Asia - the Singapore experience. In: Hered Cancer Clin Pract 4(3):126\u2013135. https:\/\/doi.org\/10.1186\/1897-4287-4-3-126","journal-title":"In: Hered Cancer Clin Pract"},{"key":"518_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cdp.2005.06.009","volume":"29","author":"TM Chin","year":"2005","unstructured":"Chin TM, Tan SH, Lim SE, Iau P, Yong WP, Wong SW, Lee SC (2005) Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians. Cancer Detect Prev 29:412\u2013418. https:\/\/doi.org\/10.1016\/j.cdp.2005.06.009","journal-title":"Cancer Detect Prev"},{"key":"518_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.breast.2019.01.002","volume":"45","author":"C Colas","year":"2019","unstructured":"Colas C, Golmard L, dePauw A, Caputo S, Stoppa-Lyonnet D (2019) \u201cDecoding hereditary breast cancer\u201d benefits and questions from multigene panel testing. Breast 45:29\u201335. https:\/\/doi.org\/10.1016\/j.breast.2019.01.002","journal-title":"Breast"},{"key":"518_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-60327-492-0_2","volume":"472","author":"YM Coyle","year":"2009","unstructured":"Coyle YM (2009) Lifestyle, genes, and cancer. Methods Mol Biol 472:25\u201356. https:\/\/doi.org\/10.1007\/978-1-60327-492-0_2","journal-title":"Methods Mol Biol"},{"key":"518_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10549-015-3374-7","volume":"151","author":"D Cragun","year":"2015","unstructured":"Cragun D, Bonner D, Kim J, Akbari MR, Narod SA, Gomez-Fuego A, Garcia JD, Vadaparampil ST, Pal T (2015) Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer. Breast Cancer Res Treat 151:169\u2013176. https:\/\/doi.org\/10.1007\/s10549-015-3374-7","journal-title":"Breast Cancer Res Treat"},{"key":"518_CR10","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1002\/cncr.30621","volume":"123","author":"D Cragun","year":"2017","unstructured":"Cragun D, Weidner A, Lewis C, Bonner D, Kim J, Vadaparampil ST, Pal T (2017) Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors. Cancer 123:2497\u20132505. https:\/\/doi.org\/10.1002\/cncr.30621","journal-title":"Cancer"},{"key":"518_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ygyno.2015.12.020","volume":"140","author":"SM Domchek","year":"2016","unstructured":"Domchek SM, Aghajanian C, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balma\u00f1a J, Mitchell G, Fried G, Stemmer SM, Hubert A, Rosengarten O, Loman N, Robertson JD, Mann H, Kaufman B (2016) Efficacy and safety of olaparib monotherapy in germline BRCA1\/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy. Gynecol Oncol 140:199\u2013203. https:\/\/doi.org\/10.1016\/j.ygyno.2015.12.020","journal-title":"Gynecol Oncol"},{"key":"518_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jad.2007.07.028","volume":"107","author":"EP Hayden","year":"2008","unstructured":"Hayden EP, Dougherty LR, Maloney B, Olino TM, Sheikh H, Durbin CE, Nurnberger JI Jr, Lahiri DK, Klein DN (2008) Early-emerging cognitive vulnerability to depression and the serotonin transporter promoter region polymorphism. J Affect Disord 107:227\u2013230. https:\/\/doi.org\/10.1016\/j.jad.2007.07.028","journal-title":"J Affect Disord"},{"key":"518_CR13","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/j.1939-0025.1974.tb00917.x","volume":"44","author":"DYF Ho","year":"1974","unstructured":"Ho DYF (1974) Relational counseling: an Asian perspective on therapeutic intervention. - PsycNET. Am J Orthopsychiatry 44:620\u2013636. https:\/\/doi.org\/10.1111\/j.1939-0025.1974.tb00917.x","journal-title":"Am J Orthopsychiatry"},{"key":"518_CR14","first-page":"426","volume":"12","author":"SM Ho","year":"2003","unstructured":"Ho SM, Ho JW, Chan CL, Kwan K, Tsui YK (2003) Decisional consideration of hereditary colon cancer genetic test results among Hong Kong chinese adults. Cancer Epidemiol Biomark Prev 12:426\u2013432","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"518_CR15","unstructured":"Hong Kong Cancer Registry, Hospital Authority (2019) Female breast cancer in 2016. Hong Kong"},{"key":"518_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1200\/jco.2014.56.2728","volume":"33","author":"B Kaufman","year":"2015","unstructured":"Kaufman B et al (2015) Olaparib monotherapy in patients with advanced cancer and a germline BRCA1\/2 mutation. J Clin Oncol 33:244\u2013250. https:\/\/doi.org\/10.1200\/jco.2014.56.2728","journal-title":"J Clin Oncol"},{"key":"518_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"M-C King","year":"2003","unstructured":"King M-C, Marks JH, Mandell JB, Group TNYBCS (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643\u2013646. https:\/\/doi.org\/10.1126\/science.1088759","journal-title":"Science"},{"key":"518_CR18","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s00268-010-0477-5","volume":"34","author":"A Kwong","year":"2010","unstructured":"Kwong A, Wong CH, Shea C, Suen DT, Choi CL (2010) Choice of management of southern Chinese BRCA mutation carriers. World J Surg 34:1416\u20131426","journal-title":"World J Surg"},{"key":"518_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10689-014-9706-7","volume":"13","author":"A Kwong","year":"2014","unstructured":"Kwong A, Chu AT, Wu CT, Tse DM (2014) Attitudes and compliance of clinical management after genetic testing for hereditary breast and ovarian cancer among high-risk Southern Chinese females with breast cancer history. Familial Cancer 13:423\u2013430. https:\/\/doi.org\/10.1007\/s10689-014-9706-7","journal-title":"Familial Cancer"},{"key":"518_CR20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jmoldx.2016.03.005","volume":"18","author":"A Kwong","year":"2016","unstructured":"Kwong A, Shin VY, Au CH, Law FBF, Ho DN, Ip BK, Wong ATC, Lau SS, To RMY, Choy G, Ford JM, Ma ESK, Chan TL (2016a) Detection of germline mutation in hereditary breast and\/or ovarian cancers by next-generation sequencing on a four-gene panel. J Mol Diagn 18:580\u2013594. https:\/\/doi.org\/10.1016\/j.jmoldx.2016.03.005","journal-title":"J Mol Diagn"},{"key":"518_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/jmedgenet-2015-103132","volume":"53","author":"A Kwong","year":"2016","unstructured":"Kwong A et al (2016b) Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. J Med Genet 53:15\u201323. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103132","journal-title":"J Med Genet"},{"key":"518_CR22","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/cncr.10420","volume":"94","author":"SC Lee","year":"2002","unstructured":"Lee SC, Bernhardt BA, Helzlsouer KJ (2002) Utilization of BRCA1\/2 genetic testing in the clinical setting: report from a single institution. Cancer 94:1876\u20131885","journal-title":"Cancer"},{"key":"518_CR23","first-page":"533","volume":"8","author":"IM Lipkus","year":"1999","unstructured":"Lipkus IM, Iden D, Terrenoire J, Feaganes JR (1999) Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. Cancer Epidemiol Biomark Prev 8:533\u2013539","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"518_CR24","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJMoa1802905","volume":"379","author":"JK Litton","year":"2018","unstructured":"Litton JK et al (2018) Talazoparib in patients with advanced breast cancer and a germline BRCA mutation New England. J Med 379:753\u2013763. https:\/\/doi.org\/10.1056\/NEJMoa1802905","journal-title":"J Med"},{"key":"518_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1037\/0033-295X.98.2.224","volume":"98","author":"HR Markus","year":"1991","unstructured":"Markus HR, Kitayama S (1991) Culture and the self: implications for cognition, emotion, and motivation. - PsycNET. Psychol Rev 98:224\u2013253. https:\/\/doi.org\/10.1037\/0033-295X.98.2.224","journal-title":"Psychol Rev"},{"key":"518_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s12282-015-0618-7","volume":"23","author":"H Nakagomi","year":"2016","unstructured":"Nakagomi H et al (2016) Willingness of Japanese patients with breast cancer to have genetic testing of BRCA without burden of expenses. Breast Cancer 23:649\u2013653. https:\/\/doi.org\/10.1007\/s12282-015-0618-7","journal-title":"Breast Cancer"},{"key":"518_CR27","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s10897-017-0096-5","volume":"26","author":"N Rajpal","year":"2017","unstructured":"Rajpal N, Munoz J, Peshkin BN, Graves KD (2017) Insights into BRCA1\/2 genetic counseling from ethnically diverse Latina breast cancer survivors. J Genet Couns 26:1221\u20131237. https:\/\/doi.org\/10.1007\/s10897-017-0096-5","journal-title":"J Genet Couns"},{"key":"518_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1706450","volume":"377","author":"M Robson","year":"2017","unstructured":"Robson M et al (2017) Olaparib for metastatic breast cancer in patients with a germline BRCA mutation N. Engl J Med 377:523\u2013533. https:\/\/doi.org\/10.1056\/NEJMoa1706450","journal-title":"Engl J Med"},{"key":"518_CR29","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/pon.3187","volume":"22","author":"KM Sussner","year":"2013","unstructured":"Sussner KM, Jandorf L, Thompson HS, Valdimarsdottir HB (2013) Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City. Psychooncology 22:1594\u20131604. https:\/\/doi.org\/10.1002\/pon.3187","journal-title":"Psychooncology"},{"key":"518_CR30","doi-asserted-by":"publisher","unstructured":"Thompson D, Easton DF (2002) Breast Cancer Linkage C Cancer incidence in BRCA1 mutation carriers J Natl Cancer Inst 94 1358-1365 doi:https:\/\/doi.org\/10.1093\/jnci\/94.18.1358","DOI":"10.1093\/jnci\/94.18.1358"},{"issue":"38","key":"518_CR31","doi-asserted-by":"publisher","first-page":"25025","DOI":"10.18632\/oncotarget.24382","volume":"9","author":"L Zhang","year":"2018","unstructured":"Zhang L et al (2018) Breast and ovarian cancer penetrance of BRCA1\/2 mutations among Hong Kong women. In: Oncotarget 9(38):25025\u201325033. https:\/\/doi.org\/10.18632\/oncotarget.24382","journal-title":"In: Oncotarget"}],"container-title":["Journal of Community Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-021-00518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12687-021-00518-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-021-00518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T12:24:39Z","timestamp":1624969479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12687-021-00518-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["518"],"URL":"https:\/\/doi.org\/10.1007\/s12687-021-00518-3","relation":{},"ISSN":["1868-310X","1868-6001"],"issn-type":[{"value":"1868-310X","type":"print"},{"value":"1868-6001","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"assertion":[{"value":"6 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The current study is not a clinical trial and ethical approval (UW09-210) had been obtained from the Institutional Review Board (IRB) of The University of Hong Kong.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}